DONANEMAB - Food and Drug Administration
- Set ID
- cf3f5efd-dd25-4b40-9eb0-4dcdd56fcfaa
- Type
- Indexing - product concept
- Effective date
- 2025-03-05
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use KISUNLA safely and effectively. See full prescribing information for KISUNLA. KISUNLA (donanemab-azbt) injection, for intravenous use Initial U.S. Approval: 2024 | Product name | Eli Lilly and Company | 2025-12-30 |
| These highlights do not include all the information needed to use KISUNLA safely and effectively. See full prescribing information for KISUNLA. KISUNLA (donanemab-azbt) injection, for intravenous use Initial U.S. Approval: 2024 | Product name | Eli Lilly and Company | 2025-08-12 |